Read More 1 minute read Analyst Ratings Downgrades News Price Target Credit Suisse Downgrades UWM Hldgs to Underperform, Lowers Price Target to $3.5 By Benzinga Newsdesk August 10, 5:09 AM Credit Suisse analyst Douglas Harter downgrades UWM Hldgs (NYSE:UWMC) from Neutral to Underperform and lowers the price target from $3.75 to $3.5. UWMC
Read More 1 minute read Analyst Ratings Downgrades News Price Target Goldman Sachs Downgrades Singular Genomics Sys to Neutral, Announces $3.5 Price Target By Benzinga Newsdesk August 10, 5:07 AM Goldman Sachs analyst Matthew Sykes downgrades Singular Genomics Sys (NASDAQ:OMIC) from Buy to Neutral and announces $3.5 price target. OMIC
Read More 1 minute read Analyst Ratings Downgrades News Price Target Jefferies Downgrades PAR Technology to Hold, Lowers Price Target to $40 By Benzinga Newsdesk August 10, 5:05 AM Jefferies analyst Samad Samana downgrades PAR Technology (NYSE:PAR) from Buy to Hold and lowers the price target from $43 to $40. PAR
Read More 1 minute read Analyst Ratings Downgrades News Price Target JP Morgan Downgrades Berkeley Lights to Neutral, Lowers Price Target to $8 By Benzinga Newsdesk August 10, 5:01 AM JP Morgan analyst Tycho Peterson downgrades Berkeley Lights (NASDAQ:BLI) from Overweight to Neutral and lowers the price target from $12 to $8. BLI
Read More 1 minute read Analyst Ratings Downgrades News JP Morgan Downgrades Minerva Surgical to Underweight By Benzinga Newsdesk August 10, 4:59 AM JP Morgan analyst Robbie Marcus downgrades Minerva Surgical (NASDAQ:UTRS) from Overweight to Underweight. UTRS
Read More 1 minute read Analyst Color Analyst Ratings Biotech Downgrades General Health Care Movers News Price Target Small Cap Trading Ideas Analysts See Softened Timelines For CRISPR Therapeutics’ Sickle Cell Candidate In US By Vandana Singh August 9, 3:26 PM Barclays says that CRISPR Therapeutics AG’s (NASDAQ: CRSP) Q2 FY22 earnings release was largely incremental, highlighting the progress of multiple clinical programs, including the… BLUE
Read More 1 minute read Analyst Ratings Downgrades Movers Small Cap Trading Ideas Why Bed Bath & Beyond Stock Is Plunging Today By Adam Eckert August 9, 11:58 AM Bed Bath & Beyond Inc (NASDAQ: BBBY) shares are trading lower Tuesday following a downgrade from Baird. AMC
Read More 1 minute read Analyst Ratings Downgrades News Price Target Hovde Group Downgrades Professional Holding to Market Perform, Announces $32 Price Target By Benzinga Newsdesk August 9, 9:49 AM Hovde Group analyst David Bishop downgrades Professional Holding (NASDAQ:PFHD) from Outperform to Market Perform and announces $32 price target. PFHD
Read More 1 minute read Analyst Ratings Downgrades News Price Target Cowen & Co. Downgrades Quanterix to Market Perform, Lowers Price Target to $18 By Benzinga Newsdesk August 9, 9:40 AM Cowen & Co. analyst Max Masucci downgrades Quanterix (NASDAQ:QTRX) from Outperform to Market Perform and lowers the price target from $38 to $18. QTRX
Read More 1 minute read Analyst Ratings Downgrades News Argus Research Downgrades Charter Communications to Hold By Benzinga Newsdesk August 9, 8:07 AM Argus Research analyst Joseph Bonner downgrades Charter Communications (NASDAQ:CHTR) from Buy to Hold. CHTR